Curebase Solutions Supports Another InBios FDA Emergency Use Authorization for COVID-19 IgG Antibody Rapid Test
- Thursday, September 30, 2021, 7:12
- Environment
- Add a comment
SAN FRANCISCO, Sept. 30, 2021 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, teamed up again this summer with InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, to test InBios’ SCoV-2 Detect IgG…
About the Author
adminasapcorp has written 38951 stories on this site.